Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

FDA grants priority review to Takeda’s colitis drug

Accelerates review time for vedolizumab

Novartis building

Novartis signs cell therapy deal with Regenerex

Involves platform that could allow transplant patients to live without lifelong immunosuppression

National Institute for Health and Care Excellence NICE logo

NICE questions cost of medicines development

Says pharma should determine if R&D spending of £1bn+ per drug is really necessary

- PMLiVE

New UK business unit head for Fishawack

Gary Lyons will lead the Fishawack Communications delivery team

- PMLiVE

Former Quintiles president Jeff Thomis to chair Idis

Will oversee company’s activities to develop managed access programmes for medicines

- PMLiVE

Otsuka to buy cancer biopharma Astex

Takes control of company behind Dacogen in $886m deal

- PMLiVE

Isis rises on positive triglyceride drug data

ISIS-APOCIII Rx can cause triglycerides to drop 75 per cent

- PMLiVE

J&J files rare blood disorder drug siltuximab in US and EU

Orphan drug to be assessed for use in the treatment of multicentric Castleman disease

Anthony Zook resigns as Vivus CEO

Replaced by former J&J executive Seth Fischer

- PMLiVE

Baxter taps Coherus for Enbrel biosimilar

Deal to develop copy of Amgen and Pfizer's arthritis and psoriasis is worth up to $246m

- PMLiVE

Salix wins rheumatology contract

Comms agency to produce Simple Tasks awareness campaign for British Society for Rheumatology

- PMLiVE

GSK splits media account between two agencies

GroupM and Omnicom are the winners in GSK’s latest consolidation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links